5 HT receptor mediated neurogenesis
US7678808B2 · kind B2 · utility
8Cited by
528References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2007 |
| Grant date | Mar 16, 2010 |
| Priority date | — |
| Expiry date | Jun 4, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The instant disclosure describes methods for treating diseases and conditions of the central and peripheral nervous system by stimulating or increasing neurogenesis. The disclosure includes compositions and methods based on use of a 5HTR agent, optionally in combination with one or more other neurogenic agents, to stimulate or activate the formation of new nerve cells.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.